Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2006 (2006), Article ID 42394, 6 pages
http://dx.doi.org/10.1155/MI/2006/42394
Research Communication

Circulating sCD138 and Some Angiogenesis-Involved Cytokines Help to Anticipate the Disease Progression of Early-Stage B-Cell Chronic Lymphocytic Leukemia

Department of Hematology, Wrocław Medical University, Pasteura 4, Wrocław 50-367, Poland

Received 4 December 2005; Revised 12 March 2006; Accepted 13 March 2006

Copyright © 2006 Dariusz Wołowiec et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E Ruoslahti and Y Yamaguchi, “Proteoglycans as modular of growth factor activities,” Cell, vol. 64, pp. 867–869, 1991. View at Publisher · View at Google Scholar
  2. M Bernfield, R Kokenyesi, M Kato et al., “Biology of the sydecans: a family of four transmembrane heparan sulphate proteoglycans,” Annual Review of Cell Biology, vol. 8, pp. 365–393, 1993. View at Publisher · View at Google Scholar
  3. K Elenius and M Jalkanen, “Function of the syndecans: a family of cell surface proteoglycans,” Journal of Cell Science, vol. 107, no. 11, pp. 2975–2982, 1994. View at Google Scholar · View at PubMed
  4. R D Sanderson, P Lalor, and M Bernfield, “B lymphocytes express and lose syndecan at specific stages of differentiation,” Cell Regulation, vol. 1, no. 1, pp. 27–35, 1989. View at Google Scholar · View at PubMed
  5. M V Dhodapkar, T Kelly, A Theus, A B Athota, B Barlogie, and R D Sanderson, “Elevated levels of shed syndecan-1 correlate with tumour mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma,” British Journal of Haematology, vol. 99, no. 2, pp. 368–371, 1997. View at Publisher · View at Google Scholar
  6. M V Dhodapkar, E Abe, A Theus et al., “Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth, and bone cell differentiation,” Blood, vol. 91, no. 8, pp. 2679–2688, 1998. View at Google Scholar
  7. R C Ridley, H Xiao, H Hata, J Woodlif, J Epstein, and R D Sanderson, “Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen,” Blood, vol. 81, no. 3, pp. 767–774, 1993. View at Google Scholar
  8. C Seidel, A Sundan, M Hjorth et al., “Serum syndecan-1: a new independent prognostic marker in multiple myeloma,” Blood, vol. 95, no. 2, pp. 388–392, 2000. View at Google Scholar
  9. A Sebestyen, L Berczi, R Mihalik, S Paku, A Matolcsy, and L Kopper, “Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas,” British Journal of Haematology, vol. 104, no. 2, pp. 412–419, 1999. View at Publisher · View at Google Scholar · View at PubMed
  10. T E Witzig, T Kimlinger, M Stenson, and T Therneau, “Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemia,” Leukemia and Lymphoma, vol. 31, no. 1-2, pp. 167–175, 1998. View at Google Scholar
  11. B D Cheson, J M Bennett, M Grever et al., “National Cancer Institute-Sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment,” Blood, vol. 87, no. 12, pp. 4990–4997, 1996. View at Google Scholar
  12. F Bertolini, M Paolucci, F Peccatori et al., “Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma,” British Journal of Haematology, vol. 106, no. 2, pp. 504–509, 1999. View at Publisher · View at Google Scholar
  13. C Basilico and D Moscatelli, “The FGF family of growth factors and oncogenes,” Advances in Cancer Research, vol. 59, pp. 115–165, 1992. View at Google Scholar
  14. A Bikfalvi and Z C Han, “Angiogenic factors are hematopoietic growth factors and vice versa,” Leukemia, vol. 8, no. 3, pp. 523–529, 1994. View at Google Scholar
  15. A Konig, T Menzel, S Lynen et al., “Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis,” Leukemia, vol. 11, no. 2, pp. 258–265, 1997. View at Publisher · View at Google Scholar · View at PubMed
  16. O Bairey, Y Zimara, M Shaklai, and E Rabizadeh, “Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia,” British Journal of Haematology, vol. 113, no. 2, pp. 400–406, 2001. View at Publisher · View at Google Scholar · View at PubMed
  17. S Duensing and J Atzpodien, “Increased intracellular and plasma levels of basic fibroblast growth factor in B-cell chronic lymphocytic leukemia,” Blood, vol. 85, no. 7, pp. 1978–1979, 1995. View at Google Scholar
  18. I Christiansen, C Gidlof, A Wallgren, B Simonsson, and T H Tottermann, “Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers,” Blood, vol. 84, no. 9, pp. 3010–3016, 1994. View at Google Scholar · View at PubMed
  19. S Molica, A Vacca, D Ribatti et al., “Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia,” Blood, vol. 100, no. 9, pp. 3344–3351, 2002. View at Publisher · View at Google Scholar
  20. S Molica, G Vitelli, D Levato, A Ricciotti, and G Digiesi, “Clinicoprognostic implications of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in early B-cell chronic lymphocytic leukaemia,” British Journal of Cancer, vol. 86, no. 1, pp. 31–35, 2002. View at Publisher · View at Google Scholar
  21. A Aguayo, H Kantarjian, T Manshouri et al., “Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes,” Blood, vol. 96, no. 6, pp. 2240–2245, 2000. View at Google Scholar · View at PubMed
  22. H Chen, A T Treeweeke, D C West et al., “In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells,” Blood, vol. 96, no. 9, pp. 3181–3187, 2000. View at Google Scholar
  23. A R Kini, N E Kay, and L C Peterson, “Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia,” Leukemia, vol. 14, no. 8, pp. 1414–1418, 2000. View at Publisher · View at Google Scholar
  24. S Molica, G Vitelli, D Levato, G M Gandolfo, and V Liso, “Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia,” British Journal of Haematology, vol. 107, no. 3, pp. 605–610, 1999. View at Publisher · View at Google Scholar
  25. M O'Reilly, T Boehm, Y Shing et al., “Endostatin: an endogenous inhibitor of angiogenesis and tumor growth,” Cell, vol. 88, no. 2, pp. 277–285, 1997. View at Google Scholar
  26. A L Feldman, H Pak, J C Yang, H R Jr Alexander, and S K Libutti, “Serum endostatin levels are elevated in patients with soft tissue sarcoma,” Cancer, vol. 91, no. 8, pp. 1525–1529, 2001. View at Publisher · View at Google Scholar
  27. A L Feldman, L Tamarkin, G F Paciotti et al., “Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer,” Clinical Cancer Research, vol. 6, no. 12, pp. 4628–4634, 2000. View at Google Scholar
  28. M Yamagata, Y Shiratori, Y Dan et al., “Serum endostatin levels in patients with hepatocellular carcinoma,” Annals of Oncology, vol. 11, no. 6, pp. 761–762, 2000. View at Publisher · View at Google Scholar
  29. J Góra-Tybor, J Z Błoński, and T Robak, “Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia,” Mediators of Inflammation, vol. 12, no. 3, pp. 167–171, 2003. View at Google Scholar
  30. R Lai, E Estey, Y Shen et al., “Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome,” Cancer, vol. 94, no. 1, pp. 14–17, 2002. View at Publisher · View at Google Scholar